These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6133641)

  • 1. Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trials.
    Friedewald WT
    Circulation; 1983 Jun; 67(6 Pt 2):I110-1. PubMed ID: 6133641
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of long-term beta-blocker trials in survivors of myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I46-9. PubMed ID: 6133644
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
    Furberg CD; Bell RL
    Circulation; 1983 Jun; 67(6 Pt 2):I83-5. PubMed ID: 6133649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta blockade in acute myocardial infarction].
    Nitter-Hauge S
    Tidsskr Nor Laegeforen; 1987 Oct; 107(28):2431-2. PubMed ID: 2891208
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
    Halawa B; Mazurek W
    Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-blockade after myocardial infarction.
    Drug Ther Bull; 1977 Apr; 15(9):33-4. PubMed ID: 17532
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of beta-adrenergic blocking agents after myocardial infarction.
    Talbert RL
    Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362
    [No Abstract]   [Full Text] [Related]  

  • 11. beta Blockade after myocardial infarction. Absence of evidence is failure of research policy.
    Lipman T
    BMJ; 2000 Feb; 320(7234):581. PubMed ID: 10744406
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenergic beta receptor blockaders as a secondary prevention after acute myocardial infarction].
    Jensen G; Sigurd B
    Ugeskr Laeger; 1981 Nov; 143(48):3241-5. PubMed ID: 6120594
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of acute-phase beta-blocker trials in patients with myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I21-5. PubMed ID: 6133643
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of the Workshop on Implications of Recent Beta-blocker Trials for Post-Myocardial Infarction Patients. May 25-26, 1982, National Institutes of Health, Bethesda, Maryland.
    Circulation; 1983 Jun; 67(6 Pt 2):I1-111. PubMed ID: 6133638
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta blocking agents in post myocardial infarction patients.
    Campbell RW; Bourke J
    Eur Heart J; 1986 May; 7 Suppl A():119-21. PubMed ID: 2873038
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction.
    Brand DA; Newcomer LN; Freiburger A; Tian H
    J Am Coll Cardiol; 1995 Nov; 26(6):1432-6. PubMed ID: 7594066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
    Furberg CD; Byington RP
    Circulation; 1983 Jun; 67(6 Pt 2):I98-101. PubMed ID: 6133654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.